Sacituzumab govitecan, sold under the brand name Trodelvy, is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate used for the treatment of metastatic triple-negative breast cancer and metastatic urothelial cancer.
Sacituzumab govitecan was approved for medical use in the United States in April 2020, and in the European Union in November 2021. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) consider it to be a first-in-class medication.
TRODELVY (sacituzumab govitecan-hziy) for injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the countries of UAE, Saudi Arabia, Argentina, Brazil, UK, Hungary, Ireland, Belgium, Lithania, Greece, Spain, Zimbabwe, Australia and India. To inquire about the cost price of purchasing TRODELVY and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
If the Brand Name medication "TRODELVY (sacituzumab govitecan-hziy) for injection" is not approved or unavailable in your country, patients, physicians, and distributors/suppliers have the option to purchase and import it from Verve Biosciences. To begin the process, you can make an enquiry, and we will assist you in calculating the total cost to buy "TRODELVY (sacituzumab govitecan-hziy) for injection" online and arrange delivery to your location. To proceed, we will require a prescription from your treating doctor, and in certain countries, an import license may also be necessary. Throughout the process, our Patient Support team will provide guidance and support.
Verve Biosciences offers assistance in importing the anti-cancer medication TRODELVY (sacituzumab govitecan-hziy) for injection. To inquire about the total cost of TRODELVY (sacituzumab govitecan-hziy) for injection in various countries, including UAE, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, as well as Europe (such as UK, Hungary, Ireland, Latvia, Slovakia, Czech Republic, Belgium, Lithania, Greece, Spain, Maldova, Germany, Sweden, Italy, Bulgaria, Romania, Montenegro, Russia), and other countries like Zimbabwe, Australia, and New Zealand, please reach out to us. We will provide you with the necessary information regarding the pricing and availability of TRODELVY (sacituzumab govitecan-hziy) for injection in the desired locations.